Munro N - Search Results

1

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).

Feher M, Hinton W, Forbes A, Munro N, Joy M, Wheeler D, de Lusignan S. Feher M, et al. Among authors: munro n. JMIR Res Protoc. 2022 Jul 19;11(7):e34206. doi: 10.2196/34206. JMIR Res Protoc. 2022. PMID: 35852840 Free PMC article.

2

Current, new, and emerging therapies for managing hyperglycaemia in type 2 diabetes.

Munro N, Feher MD. Munro N, et al. Br J Gen Pract. 2008 Aug;58(553):531-3. doi: 10.3399/bjgp08X319684. Br J Gen Pract. 2008. PMID: 18682016 Free PMC article. No abstract available.

3

Fixed-dose combinations in diabetes--do they improve medication adherence?

Feher MD, Munro N, Watters K. Feher MD, et al. Among authors: munro n. Diabet Med. 2010 Jul;27(7):735-6. doi: 10.1111/j.1464-5491.2010.03023.x. Diabet Med. 2010. PMID: 20636951 No abstract available.

4

QTc prolongation and diabetes therapies.

Watters K, Munro N, Feher M. Watters K, et al. Among authors: munro n. Diabet Med. 2012 Mar;29(3):290-2. doi: 10.1111/j.1464-5491.2011.03520.x. Diabet Med. 2012. PMID: 22060961 No abstract available.

5

Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus.

Feher M, Greener M, Munro N. Feher M, et al. Among authors: munro n. Diabetes Metab Syndr Obes. 2013;6:11-5. doi: 10.2147/DMSO.S35053. Epub 2013 Jan 10. Diabetes Metab Syndr Obes. 2013. PMID: 23341741 Free PMC article.

6

Diabetes screening after gestational diabetes in England: a quantitative retrospective cohort study.

McGovern A, Butler L, Jones S, van Vlymen J, Sadek K, Munro N, Carr H, de Lusignan S. McGovern A, et al. Among authors: munro n. Br J Gen Pract. 2014 Jan;64(618):e17-23. doi: 10.3399/bjgp14X676410. Br J Gen Pract. 2014. PMID: 24567578 Free PMC article.

7

Getting on with your computer is associated with job satisfaction in primary care: entrants to primary care should be assessed for their competency with electronic patient record systems.

de Lusignan S, Pearce C, Munro N. de Lusignan S, et al. Among authors: munro n. Inform Prim Care. 2013;21(1):i-iii. doi: 10.14236/jhi.v21i1.61. Inform Prim Care. 2013. PMID: 24629650 Free article.

8

Basing approval of drugs for type 2 diabetes on real world outcomes.

McGovern A, Hinchliffe R, Munro N, de Lusignan S. McGovern A, et al. Among authors: munro n. BMJ. 2015 Nov 3;351:h5829. doi: 10.1136/bmj.h5829. BMJ. 2015. PMID: 26530057 No abstract available.

9

Creating and using real-world evidence to answer questions about clinical effectiveness.

de Lusignan S, Crawford L, Munro N. de Lusignan S, et al. Among authors: munro n. J Innov Health Inform. 2015 Nov 4;22(3):368-73. doi: 10.14236/jhi.v22i3.177. J Innov Health Inform. 2015. PMID: 26577427 Free article.

10

Glucose test provenance recording in UK primary care: was that fasted or random?

McGovern AP, Fieldhouse H, Tippu Z, Jones S, Munro N, de Lusignan S. McGovern AP, et al. Among authors: munro n. Diabet Med. 2017 Jan;34(1):93-98. doi: 10.1111/dme.13067. Epub 2016 Feb 11. Diabet Med. 2017. PMID: 26773331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters